Wing J K
J Med Ethics. 1975 Dec;1(4):174-5. doi: 10.1136/jme.1.4.174.
In summary, the discussion by Professors Helmchen and Müller-Oerlinghausen of the morality of clinical trials has emphasized a point that is frequently overlooked. It is an essential to consider those situations in which it might be unethical not to conduct a trial as it is to be concerned about the ways in which trials might restrict the rights of the individuals taking part in them. They and I have dealt mainly with the first of these two issues because it has been relatively neglected. The second is, of course, equally important and has rightly received much attention. Both matters deserve further public discussion.
总之,赫尔姆兴教授和米勒 - 厄林豪森教授关于临床试验道德性的讨论强调了一个经常被忽视的要点。既要关注临床试验可能限制参与试验个体权利的方式,同样重要的是,也要考虑那些不进行试验可能不道德的情况。他们和我主要探讨了这两个问题中的第一个,因为它相对受到忽视。第二个问题当然同样重要,并且理所当然地受到了很多关注。这两个问题都值得进一步公开讨论。